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Prevalence of genital chlamydial infection in 
symptomatic and asymptomatic Jordanian patients 
Ziad M. Awwad,(l) Arwa A. Al-Amaratc2) and Asem A. Shehabic2) 
Objective: To detect Chlamydia trachomatis infection among 230 patients, 130 with signs or symptoms associated 
with urethritis, and 100 asymptomatic patients, attending the Jordan University Hospital urology clinic. 
Methods: Routine urine examination and the leukocyte esterase test were done for each patient. C. trachomatis 
infection was detected using first-void urine specimens and a cryptic plasmid-based PCR technique specific for C. 
trachomatis. 
Results: The prevalence of chlamydial infection was 4.6% among symptomatic patients with urethritis. The difference 
in prevalence was statistically insignificant (P > 0.05) between males and females, as well as in relation to their marital 
status. Two-thirds of the Chlamydia-positive patients also had urine positive for leukocyte esterase. 
Conclusion: The low prevalence of chlamydial infection in association with urethritis among Jordanian patients might 
be due to the conservative behavior of the Jordanian society towards free sexuality. 
Int J Infect Dis 2003; 7: 206-209 
INTRODUCTION 
Chlamydia trachomatis is the most prevalent bacterial 
cause of sexually transmitted infections in men and 
women wor1dwide.Q Genital chlamydial infection is the 
most commonly reported notifiable infectious disease in 
the USA, with an annual estimate of approximately 
3 million cases.3 Up to 75% of women infected with C. 
trachomatis are symptom-free, and in men, the rate of 
asymptomatic chlamydial infection is higher than the 
rate of symptomatic gonorrhea1 infection.G There is 
also a higher prevalence of chlamydial infection among 
young people, associated with symptomatic and 
asymptomatic urethritis. Therefore, screening of sexually 
active women is an effective measure in the prevention 
of pelvic inflammatory disease with subsequent risk for 
infertility. 2,7 Chronic genital chlamydial infection in men 
may also result in infertility.7 Since chlamydial infection 
is frequently mild or asymptomatic, a specific and 
sensitive detection method using first-void urine and 
PCR has recently proved to be more reliable and than 
other diagnostic methods in both men and women.8-11 
The aim of this study was to determine the 
prevalence of genital chlamydial infection in 
symptomatic and asymptomatic Jordanian patients 
attending urology clinics, using first-void urine and PCR. 
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PATIENTS AND METHODS 
Patients 
In total, 230 Jordanian patients attending the urology 
clinic at Jordan University Hospital in Amman, during 
the period from March to November 2000, were 
included in this study. Patients were divided into two 
groups. The first included 130 patients, 70 males (mean 
age 34 years) and 60 females (mean age 23 years); they 
were suffering from at least two of the following signs or 
symptoms suggestive of urethritis-dysuria, itching, 
irritation, urethral discharge, or pain. The second group 
included 100 patients, 61 males (mean age 3.5 years) and 
39 females (mean age 30 years). This control group was 
composed of patients attending the urology clinic for 
complaints other than urethritis, such as renal stones, 
varicocele, and bladder outflow obstruction. All patients 
and controls were of sexually active age, had not been 
treated with antibiotics during the previous 4 weeks, and 
had given their signed consent to be included in this 
study. No attempt was made to ask about their sexual 
habits. 
Urine specimen 
First-void urine specimens were collected in sterile leak- 
proof containers from all patients included in the study. 
Each urine specimen was processed within 1 h after 
collection, and was divided into two parts. Microscopic 
urine examination and a leukocyte esterase dipstick test 
were done for each patient; 8 mL of urine was 
centrifuged at 35OOg for 5 min in a conical tube, and the 
sediments were transferred to a microcentrifuge tube 
for further DNA examination. 
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DNA extraction and amplification 
The urine sediments were either used on the same day 
for DNA extraction, or kept frozen at -20°C for l-2 
weeks until DNA extraction and PCR were done. Both 
the proteinase K methodI and a commercial genomic 
DNA extraction kit (Promega, Madison, WI, USA) were 
used to extract chlamydial DNA from urine sediments. 
To confirm the presence of DNA after completion of 
the extraction process, samples were subjected to 2% 
agarose gel electrophoresis and stained by ethidium 
bromide, and the presence of DNA was assessed under 
UV light. The extracted DNA was then ready for 
amplification by PCR, as described by Mahony et al.ll 
The primers KLl/KL2 for detection of C. truchonzatis 
were derived from the sequence of the genetically 
conserved cryptic plasmid of C. trachomatis, which is 
common to all serovariants of C. trachomatis;ll a specific 
241-base-pair amplified product was generated, and 
served as an amplification target. In order to identify the 
size of the target sequence amplified, the DNA 
molecular marker @X147 HaeIII was also added to 
each run, to determine the 241-base-pair sequence that 
is the amplified target from the specific KLlIKL2 
primers.ll 
were patients with signs or symptoms suggestive of 
urethritis, and 100 were asymptomatic patients used 
as controls. Table 1 shows that the prevalence of C. 
trachomatis among the symptomatic group was 61130 
(4.6%), compared to none among the control group; this 
represents a statistically significant difference (P < 0.05). 
The results of the leukocyte esterase test correlated with 
Chlamydia-positive cases (4/6,66.7%, P<O.O5), but were 
considered not significant compared with Chlumydia- 
negative cases (35/124, P > 0.05) (Table 2). 
Table 3 shows that 5/115 (4.3%) patients with 
dysuria, 3/12 (25%) patients with discharge, 3/15 
(16.6%) patients with itching and 2/29 (6.5%) patients 
with irritation were positive for chlamydial infection. 
These results indicate that the presence of symptoms 
such as discharge or itching is statistically significant 
(P < 0.05), whereas the presence of dysuria or irritation 
is statistically insignificant (P > 0.5). 
Table 4 shows the prevalence of C. trachomatis in 
symptomatic patients according to their sex and marital 
status. The difference in the prevalence of C. trachomatis 
between males and females as well as in relation to 
marital status was statistically insignificant (P > 0.05). 
DISCUSSION 
Statistical analysis 
All data were analyzed statistically using the Statistical 
Package for Social Science (SPSS) program; the t-test 
and analysis of variation (ANOVA) were used to 
determine statistical significance. 
The prevalence of C. trachomatis has been determined 
in several areas of the world, and the prevalence varies 
according to the geographic area, age of the patient, 
and whether or not the clinic specializes in sexually 
transmitted diseases.4,7 In the USA, the prevalence of 
C. trachomatis genital infections among sexually active 
RESULTS 
In total, 230 first-void urine specimens were tested for 
the presence of C. trachomatis infection. Of these, 130 
Table 3. Prevalence of positive Chlamydia trachomatis among 
130 patients associated with signs or symptoms of urethritis 
Table 1. Prevalence of Chlamydia trachomatis among 
symptomatic and asymptomatic patients (control) 
Chlamydia test 












C. trachomatis Total 
No. (“/o) 
6 (4.6) 130 
0 100 
6 (2.6) 230 
Dysuria no. (%) 5 (4.3) 110 (95.7) 115 
Discharge no. (%)b 3 (25.0) 9 (75.0) 12 
Itching no. (%)b 3 (16.7) 15 (83.3) 18 
Irritation no. (%) 2 (6.5) 29 (93.5) 31 
a Each patient complained of one or more symptoms. 
b t-test (PcO.05). 
Table 2. Association of Chlamydia infection with positive 
leukocyte esterase test in symptomatic patients 
Table 4. Prevalence of Chlamydia trachomatis infection in 130 
symptomatic patients according to their sex and marital status 
Chlamydia test (PCR) 
Patients 
(Leukocyte No. positive cases No. negative cases 
esterase test) (6) 024 
No. positive (%) 4 (66.7)a 35 (28.2) 
No. negative (%) 2 (33.3) 89 (71.8) 
at-test (P~0.05) in association with positive Chlamydia test. 
Chlamydia test Sex Marital status 
Male Female Married” Singleb 
(70) (60) (100) PO) 
No. positive (%) 4 (5.7) 2 (3.3) 4 (4) 2 (6.7) 
No. negative(%) 66 (94.3) 58 (96.7) 96 (96) 28 (93.3) 
t-test (P>O.O5): a each two males and females; b Only males. 
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adolescents is 5-15 %, regardless of socioeconomic 
status,13,14 whereas in the UK the prevalence of C. 
trachomatis infection varies considerably among 
different populations (range l-29%); the median 
prevalence is 16% in women attending genitourinary 
clinics.15 A recent study found that young adults who 
travel abroad have significant risk for the acquisition of 
C. trachomatis infection. In this group, urethritislcystitis 
and vaginal discharge were the prevalent manifestations 
of illness among females, while urethritis was the only 
clinical condition found in males.5 
Several studies have reported that first-void urine 
specimens examined with the PCR method could be 
used for the detection of C. trachomatis in men and 
women, with sensitivity and specificity greater than 
those of other diagnostic methods.8-10 PCR testing of 
urine for the detection of C. trachomatis has great 
potential for the screening of men, who represent an 
important reservoir of infection for women. This test has 
the advantages of ease of collection and transport, patient 
acceptability, and high sensitivity and specificity.9,11 
The prevalence of C. trachomatis in patients with 
clinically suspected urethritis was 4.6%, whereas none of 
the 100 control patients had chlamydial infection, a 
difference that was statistically significant (P < 0.05). The 
study also demonstrated no significant difference in the 
prevalence of chlamydial infection in relation to marital 
status and age, although most patients with chlamydial 
infection belong to the young age group of 16-35 years. 
In addition, patients with a positive Chlamydia test were 
treated with antibiotics, and their clinical symptoms 
resolved, but their urine was not re-examined by the 
PCR test. 
In this study, two-thirds of Chlamydia-positive 
samples were also leukocyte esterase positive. This test 
may confirm the diagnosis of urethritis, but it is not 
specific and cannot be relied upon to determine the 
causative agent of the urethral inflammati0n.l Also, 
Chernesky reported that the leukocyte esterase dipstick 
test as a marker for urethritis can be used as a screening 
test for C. trachomatis infection, but usually lacks 
specificity.lO When the patient has recurrent symptoms 
and is receiving treatment, he will probably not have 
detectable leukocytes in his urine. However, with PCR 
testing, the result for chlamydial infection remains 
positive even after weeks of treatment, because the test 
is capable of detecting the presence of nonviable 
chlamydial DNA. lo In general, studies carried out in 
university health clinics or general gynecology clinics 
tend to show lower incidence rates of chlamydial 
infecti0n.l 
The rate of sexually transmitted diseases, including 
chlamydial infection, in Jordan is not precisely known, 
as stated in the annual report of the Jordanian Ministry 
of Health, 1999.16 Also, no published studies were found 
on the estimation of the prevalence of chlamydial 
genital infection in Jordan and most other Arab 
countries using molecular techniques. However, the 
prevalence of sexually transmitted diseases in Jordan, 
including C. trachomatis genital infection, is expected to 
be lower than that in the Western world, and this may be 
because the Jordanian population is culturally and 
socially conservative in its attitudes towards free 
sexuality. In addition, this study was carried out on 
patients attending a general urology clinic, which might 
have contributed to the low prevalence of C. trachomatis 
infection among our symptomatic patients. 
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